Our team is the most important asset and brings together a unique blend of expertise and passion to drive groundbreaking advancements in cancer prevention therapeutics.
With our scientific oncology leader driving innovative research and development, our machine learning leader harnessing cutting-edge technology for precision insights, and our commercial leader propelling strategic growth and partnerships, we are at the forefront of revolutionising how early-stage cancer preventative therapeutics are assessed.
Together, we are committed to translating scientific discovery into impactful solutions that redefine standards of care and empower healthier futures worldwide. IntercepTx emerged as a spinout based on the work carried out in Prof. Walid Khaled’s lab at the University of Cambridge www.wtklab.com.
Let's create a world where cancer prevention is proactive, effective, and accessible for all.
